H. Winkler and R. Fischer-colbrie, The chromogranins A and B: The first 25 years and future perspectives, Neuroscience, vol.49, issue.3, pp.497-528, 1992.
DOI : 10.1016/0306-4522(92)90222-N

L. Taupenot, K. Harper, O. Connor, and D. , The Chromogranin???Secretogranin Family, New England Journal of Medicine, vol.348, issue.12, pp.1134-1183, 2003.
DOI : 10.1056/NEJMra021405

O. Connor, D. Deftos, and L. , Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms, New England Journal of Medicine, vol.314, issue.18, pp.1145-51, 1986.
DOI : 10.1056/NEJM198605013141803

O. Connor, D. Takiyyuddin, M. Cervenka, J. Parmer, R. Barbosa et al., Circulating chromogranin A as a diagnostic tool in clinical chemistry, Acta Histochem, vol.38, pp.27-33, 1990.

R. Ischia, R. Gasser, R. Fischer-colbrie, U. Eder, A. Pagani et al., Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.1, pp.355-60, 2000.
DOI : 10.1210/jc.85.1.355

L. Ferrari, E. Seregni, E. Bajetta, A. Martinetti, and E. Bombardieri, The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours, Anticancer Res, vol.19, pp.3415-3442, 1999.

N. Kimura, S. Hoshi, M. Takahashi, S. Takeha, S. Shizawa et al., Plasma Chromogranin a in Prostatic Carcinoma and Neuroendocrine Tumors, The Journal of Urology, vol.157, issue.2, pp.565-573, 1997.
DOI : 10.1016/S0022-5347(01)65203-0

E. Baudin, J. Bidart, A. Bachelot, M. Ducreux, D. Elias et al., Impact of chromogranin A measurement in the work-up of neuroendocrine tumors, pp.79-82, 2001.

L. Guignat, J. Bidart, M. Nocera, E. Comoy, M. Schlumberger et al., Chromogranin A and the ?? -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma, British Journal of Cancer, vol.84, issue.6, pp.808-820, 2001.
DOI : 10.1054/bjoc.2000.1677

K. Sekiya, M. Ghatei, M. Salahuddin, A. Bishop, Q. Hamid et al., Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value., Journal of Clinical Investigation, vol.83, issue.6, pp.1834-1876, 1989.
DOI : 10.1172/JCI114089
URL : http://www.jci.org/articles/view/114089/files/pdf

D. Yasuda, H. Iguchi, A. Funakoshi, H. Wakasugi, K. Sekiya et al., Comparison of Plasma Pancreastatin and GAWK Concentrations, Presumed Processing Products of Chromogranin A and B, in Plasma of Patients with Pancreatic Islet Cell Tumors, Hormone and Metabolic Research, vol.25, issue.11, pp.593-598, 1993.
DOI : 10.1055/s-2007-1002184

D. Vieau, A. Rojas-miranda, J. Verley, F. Lenne, and X. Bertagna, The secretory granule peptides 7B2 and CCB are sensitive biochemical markers of neuro-endocrine bronchial tumours in man, Clinical Endocrinology, vol.43, issue.4, pp.319-344, 1991.
DOI : 10.1007/BF02890062

R. Ischia, A. Hobisch, R. Bauer, U. Weiss, R. Gasser et al., ELEVATED LEVELS OF SERUM SECRETONEURIN IN PATIENTS WITH THERAPY RESISTANT CARCINOMA OF THE PROSTATE, The Journal of Urology, vol.163, issue.4, pp.1161-1165, 2000.
DOI : 10.1016/S0022-5347(05)67714-2

Y. Anouar, S. Jegou, D. Alexandre, I. Lihrmann, J. Conlon et al., Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides, FEBS Letters, vol.66, issue.3, pp.295-304, 1996.
DOI : 10.1046/j.1471-4159.1996.66062248.x

M. Montero-hadjadje, G. Pelletier, Y. L. Li, S. Guillemot, J. Magoul et al., Biochemical Characterization and Immunocytochemical Localization of EM66, a Novel Peptide Derived from Secretogranin II, in the Rat Pituitary and Adrenal Glands, Journal of Histochemistry & Cytochemistry, vol.60, issue.8, pp.1083-95, 2003.
DOI : 10.1074/jbc.275.17.12553
URL : https://hal.archives-ouvertes.fr/hal-01706425

Y. Anouar, C. Desmoucelles, Y. L. Leprince, J. Breault, L. Gallo-payet et al., Identification of a novel secretogranin II-derived peptide (SgII(187?252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide, J Clin Endocrinol Metab, vol.83, pp.2944-51, 1998.
URL : https://hal.archives-ouvertes.fr/hal-01706430

L. Yon, J. Guillemot, M. Montero-hadjadje, L. Grumolato, J. Leprince et al., Malignant Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2579-85, 2003.
DOI : 10.1210/jc.2002-021748
URL : https://hal.archives-ouvertes.fr/hal-01706414

A. Gimenez-roqueplo, J. Favier, R. P. Rieubland, C. Crespin, M. Nau et al., Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaechromocytomas, Cancer Res, vol.63, pp.5615-5636, 2003.

H. Neumann, C. Pawlu, M. Peczkowska, B. Bausch, S. Mcwhinney et al., Distinct Clinical Features of Paraganglioma Syndromes Associated With <EMPH TYPE="ITAL">SDHB</EMPH> and <EMPH TYPE="ITAL">SDHD</EMPH> Gene Mutations, JAMA, vol.292, issue.8, pp.943-51, 2004.
DOI : 10.1001/jama.292.8.943
URL : http://jama.jamanetwork.com/data/journals/jama/4941/joc32091.pdf

G. Eisenhofer, S. Bornstein, F. Brouwers, N. Cheung, P. Dahia et al., Malignant pheochromocytoma: current status and initiatives for future progress, Endocrine Related Cancer, vol.11, issue.3, pp.423-459, 2004.
DOI : 10.1677/erc.1.00829
URL : http://erc.endocrinology-journals.org/content/11/3/423.full.pdf

E. Grouzmann, M. Fathi, M. Gillet, A. De-torrente, C. Cavadas et al., Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma, Clin Chem, vol.47, pp.1075-82, 2001.

G. Eisenhofer, H. Keiser, P. Friberg, E. Mezey, T. Huynh et al., -Methyltransferase Within Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.83, issue.6, pp.2175-85, 1998.
DOI : 10.1210/jcem.83.6.4870

A. Sawka, A. Gafni, L. Thabane, W. Young, and J. , The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2859-66, 2004.
DOI : 10.1210/jc.2003-031127

Y. Anouar, L. Macarthur, J. Cohen, A. Iacangelo, and L. Eiden, Identification of a TPA-responsive element mediating preferential transactivation of the galanin gene promoter in chromaffin cells, J Biol Chem, vol.269, pp.6823-6854, 1994.

C. Cavadas, A. Silva, F. Mosimann, M. Cotrim, C. Ribeiro et al., NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.12, pp.5956-63, 2001.
DOI : 10.1210/jcem.86.12.8091

N. Kimura, W. Miura, T. Noshiro, K. Mizunashi, K. Hanew et al., Plasma Chromogranin A in Pheochromocytoma, Primary Hyperparathyroidism and Pituitary Adenoma in Comparison with Catecholamine, Parathyroid Hormone and Pituitary Hormones., Endocrine Journal, vol.44, issue.2, pp.319-346, 1997.
DOI : 10.1507/endocrj.44.319

E. Baudin, A. Gigliotti, M. Ducreux, J. Ropers, E. Comoy et al., Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours, British Journal of Cancer, vol.78, issue.8, pp.1102-1109, 1998.
DOI : 10.1038/bjc.1998.635

F. Rao, H. Keiser, O. Connor, and D. , Malignant Pheochromocytoma : Chromaffin Granule Transmitters and Response to Treatment, Hypertension, vol.36, issue.6, pp.1045-52, 2000.
DOI : 10.1161/01.HYP.36.6.1045

M. Stridsberg, B. Eriksson, K. Oberg, and E. Janson, A comparison between three commercial kits for chromogranin A measurements, Journal of Endocrinology, vol.177, issue.2, pp.337-378, 2003.
DOI : 10.1677/joe.0.1770337

K. Borch, M. Stridsberg, P. Burman, and J. Rehfeld, Basal Chromogranin a and Gastrin Concentrations in Circulation Correlate to Endocrine Cell Proliferation in Type-A Gastritis, Scandinavian Journal of Gastroenterology, vol.110, issue.3, pp.198-202, 1997.
DOI : 10.3109/00365517209081114

M. Stridsberg and E. Husebye, Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma, European Journal of Endocrinology, vol.136, issue.1, pp.67-73, 1997.
DOI : 10.1530/eje.0.1360067

S. Sanduleanu, D. Bruine, A. Stridsberg, M. Jonkers, D. Biemond et al., Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy, European Journal of Clinical Investigation, vol.104, issue.9, pp.802-813, 2001.
DOI : 10.1210/jc.84.8.2712

J. Lenders, K. Pacak, M. Walther, W. Linehan, M. Mannelli et al., Biochemical Diagnosis of Pheochromocytoma, JAMA, vol.287, issue.11, pp.1427-1461, 2002.
DOI : 10.1001/jama.287.11.1427

P. Plouin, A. Gimenez-roqueplo, L. Batide-alanore, A. Salenave, S. Duclos et al., Progr??s r??cents dans le diagnostic, l?????valuation pronostique et le traitement des ph??ochromocytomes, La Revue de M??decine Interne, vol.21, issue.12, pp.1075-85, 2000.
DOI : 10.1016/S0248-8663(00)00268-X

W. Raber, W. Raffesberg, M. Bischof, C. Scheuba, B. Niederle et al., Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma, Archives of Internal Medicine, vol.160, issue.19, pp.2957-63, 2000.
DOI : 10.1001/archinte.160.19.2957

G. Eisenhofer, D. Goldstein, M. Walther, P. Friberg, J. Lenders et al., Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2656-66, 2003.
DOI : 10.1210/jc.2002-030005

H. Lefebvre, Les pseudo-ph eochromocytomes m edicamenteux, Med Ther Endocrinol, vol.4, pp.149-55, 2002.

M. Stridsberg, U. Hellman, E. Wilander, G. Lundqvist, K. Hellsing et al., Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments, Journal of Endocrinology, vol.139, issue.2, pp.329-366, 1993.
DOI : 10.1677/joe.0.1390329

M. Stridsberg, K. Oberg, Q. Li, U. Engstrom, and G. Lundqvist, Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours, Journal of Endocrinology, vol.144, issue.1, pp.49-59, 1995.
DOI : 10.1677/joe.0.1440049

R. Hsiao, M. Mezger, O. Connor, and D. , Chromogranin A in uremia: Progressive retention of immunoreactive fragments, Kidney International, vol.37, issue.3, pp.955-64, 1990.
DOI : 10.1038/ki.1990.71

P. Gadroy, M. Stridsberg, C. Capon, J. Michalski, J. Strub et al., ) from Urine of Patients with Carcinoid Tumors, Journal of Biological Chemistry, vol.191, issue.51, pp.34087-97, 1998.
DOI : 10.1677/joe.0.1440049

H. Neumann, Imaging vs Biochemical Testing for Pheochromocytoma, JAMA: The Journal of the American Medical Association, vol.288, issue.3, pp.314-329, 2002.
DOI : 10.1001/jama.288.3.314

M. Noblet-dick, F. Grunenberger, B. Brunot, D. Jaeck, and J. Schlienger, Le ph??ochromocytome en m??decine interne : particularit??s et place de la scintigraphie ?? la MIBG 123, La Revue de M??decine Interne, vol.24, issue.6, pp.358-65, 2003.
DOI : 10.1016/S0248-8663(03)00074-2